Accelerate Cures/Treatments for All Dementias (ACT-AD), in collaboration with the Lewy Body Dementia Association, is hosting an hour-long webinar on cutting-edge research on Lewy Body dementia (LBD). The webinar will cover LBD as a priority for drug development, the genetic overlap between LBD and other forms of dementia, and LBD biomarkers.
This webinar is only open to ACT-AD members and sponsors. Membership is free for nonprofit and advocacy organizations. To learn more, including details on how to register and become a member, please email Ryne Carney at [email protected]
James E. Galvin, MD, MPH, is a professor at the University of Miami Miller School of Medicine. He is founding Director of the Comprehensive Center for Brain Health and professor of nursing at the Christine E. Lynn College of Nursing, Florida Atlantic University.
José Brás, Ph.D. is a leading molecular geneticist whose research focuses on how genetic variability impacts the onset and progression of neurodegenerative diseases. Dr. Brás joined Van Andel Institute’s Center for Neurodegenerative Science as an associate professor.
Rita Guerreiro, Ph.D. is a leader in parsing the genetic variations that contribute to neurodegenerative diseases. In 2018, she joined Van Andel Institute’s Center for Neurodegenerative Science as an associate professor.
Doug Galasko, M.D. is the associate director of the UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center and has carried out research into Alzheimer’s and related disorders for over 25 years. He is also board-certified in neurology, with special expertise in memory disorders.